Quality assessment | No. of patients | Effect | Quality | Importance | ||||||
---|---|---|---|---|---|---|---|---|---|---|
No. of studies | Design | Limitations | Inconsistency | Indirectness | Imprecision | IP groups | SP groups | |||
Total blood loss | ||||||||||
4 | RCT | Serious limitations | No serious inconsistency | No serious indirectness | No serious imprecision | 142 | 151 | WMD = 7.92, 95% CI 1.15 to 14.68 | High | Critical |
VAS scores | ||||||||||
4 | RCT | Serious limitations | No serious inconsistency | No serious indirectness | No serious imprecision | 142 | 151 | WMD = 0.70, 95% CI 0.570 to 0.83 | High | Critical |
Range of motion | ||||||||||
3 | RCT | Serious limitations | No serious inconsistency | No serious indirectness | No serious imprecision | 112 | 113 | WMD = − 1.28, 95% CI − 3.16 to 0.59 | High | Critical |
Lysholm knee scores | ||||||||||
3 | RCT | Serious limitations | No serious inconsistency | No serious indirectness | No serious imprecision | 112 | 113 | WMD = − 5.58, 95% CI − 7.33 to − 3.83 | High | Critical |
Fluoroscopy times | ||||||||||
2 | RCT | Serious limitations | Serious inconsistency | No serious indirectness | No serious imprecision | 111 | 119 | WMD = 26.70, 95% CI 3.15 to 50.25 | Moderate | Critical |
Length of hospital stay | ||||||||||
3 | RCT | Serious limitations | No serious inconsistency | No serious indirectness | No serious imprecision | 125 | 130 | WMD = − 0.05, 95% CI − 0.33 to 0.23 | High | Critical |
Postoperative complications | ||||||||||
3 | RCT | Serious limitations | No serious inconsistency | No serious indirectness | No serious imprecision | 125 | 130 | RD = 0.01, 95% CI − 0.03 to 0.04 | High | Critical |